NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000572

Registered date:10/01/2007

Efficacy and safety of first-line Vinorelbine single agent in patints with refractory to anthracycline and taxane

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedFirst-line metastatic breast cancer
Date of first enrollment2006/11/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)vinorelbine

Outcome(s)

Primary OutcomeTime to progression
Secondary OutcomeResponse rate, toxicity

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum75years-old
GenderFemale
Include criteria
Exclude criteria1) had another chemotherapy after recurrence 2) having active multiple cancers 3) having serious infenction or severe organ function

Related Information

Contact

public contact
Name Masataka Sawaki
Address 65 tsurumai-cho showa-ku Nagoya City Japan
Telephone 052-744-2251
E-mail sawapi@qc4.so-net.ne.jp
Affiliation Nagoya University school of medicine Department of Breast and Endocrine surgery
scientific contact
Name Tsuneo Imai
Address 65 tsurumai-cho showa-ku Nagoya City Japan
Telephone 052-744-2251
E-mail m-sawaki@aichi-cc.jp
Affiliation Nagoya University school of medicine Department of Breast and Endocrine surgery